- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05170997
Strategies to Improve Iodine Status in Early Pregnancy
February 6, 2024 updated by: Jayne Woodside, PhD, Queen's University, Belfast
This study aims to investigate the benefit of increased intake of cows' milk during pregnancy on iodine status.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Women of child bearing age, and those who are currently pregnant, have been found to be iodine deficient in the United Kingdom (UK).
Dairy products are an essential source of iodine in the UK as iodised salt is not widely available.
This study will ask women in the intervention group to drink approximately one pint of milk a day for 12 weeks during pregnancy.
Study Type
Interventional
Enrollment (Actual)
119
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Belfast, United Kingdom, BT12 6BA
- Royal Jubilee Maternity Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- women at 6-16 weeks pregnant
- women receiving antenatal care within Belfast Health and Social Care Trust
Exclusion Criteria:
- women with known thyroid disease currently taking thyroid medication
- women with type one diabetes
- women under 18 years of age
- those unable to provide informed consent
- women with abnormal thyroid function tests at booking appointment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Iodine Control
Participants taking an iodine-containing multivitamin or supplement and randomly allocated not to receive milk supply.
|
All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.
|
|
Active Comparator: No Iodine Control
Participants not taking an iodine-containing multivitamin or supplement and randomly allocated not to receive milk supply.
|
All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.
|
|
Experimental: Iodine Intervention
Participants taking an iodine-containing multivitamin or supplement and randomly allocated to receive milk supply.
|
All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.
Intervention groups will receive a free 12 week supply of cows' milk equating to a pint a day for study participants.
Milk is provided by Lakeland dairies.
|
|
Experimental: No Iodine Intervention
Participants not taking an iodine-containing multivitamin or supplement and randomly allocated to receive milk supply.
|
All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.
Intervention groups will receive a free 12 week supply of cows' milk equating to a pint a day for study participants.
Milk is provided by Lakeland dairies.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urinary iodine concentration
Time Frame: 18 months
|
Proportion of the maternal cohort who achieve WHO urinary iodine concentration(UIC) of >=150 micrograms/litre on early morning spot urinary sampling at 12 weeks post intervention.
|
18 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Iodine knowledge
Time Frame: 24 months
|
Knowledge regarding iodine intake in the diet in pregnancy and into postpartum assessed using an iodine knowledge questionnaire that will be completed by participants at the beginning and the end of the study period.
|
24 months
|
|
Iodine intake
Time Frame: 24 months
|
Intake of iodine rich foods at 29 weeks and postpartum in those who breastfeed will be assessed using four day food diaries at the beginning and end of the study, and validated iodine-specific food frequency questionnaires at the beginning of the study, at the end of the intervention period, six weeks after the end of the intervention period and at the end of the study.
|
24 months
|
|
Offspring
Time Frame: 24 months.
|
Proportion of offspring with adequate UIC at 6-12 weeks old.
|
24 months.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Karen Mullan, MD, Belfast Health and Social Care Trust
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 14, 2021
Primary Completion (Actual)
July 21, 2023
Study Completion (Actual)
August 3, 2023
Study Registration Dates
First Submitted
November 25, 2021
First Submitted That Met QC Criteria
December 9, 2021
First Posted (Actual)
December 28, 2021
Study Record Updates
Last Update Posted (Estimated)
February 7, 2024
Last Update Submitted That Met QC Criteria
February 6, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- B20/32
- EAT/5578/19 (Other Grant/Funding Number: Public Health Agency R&D fellowship)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
The University of Texas Health Science Center at...The University of Texas at San AntonioCompleted
-
Gynuity Health ProjectsCuidado Integral de la Mujer, Gineclinic, S.C.; Servicios de Salud Medieg,...Not yet recruitingPregnancy Related | Pregnancy Early
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
Université Catholique de LouvainRecruiting
-
Oregon Health and Science UniversityRecruitingPregnancy RelatedUnited States
-
Biorithm Pte LtdRecruiting